Table 2.
Same separation | Differing separation | Differing separation | Sig. | ||
---|---|---|---|---|---|
Low M50 and high D50 | High M50 and low D50 | ||||
n = 164 | n = 58 | n = 29 | n = 29 | ||
M50 in months | 14.9 (8.19–29.7) | 14.6 (10.7–22.0) | 10.8 (8.10–13.0) | 21.7 (16.8–27.7) | *** |
MUSIX200 in months | 19.0 (10.1–34.0) | 13.5 (8.83–19.7) | 10.8 (8.19–13.7) | 18.6 (13.2–23.3) | *** |
CMAP50 in months$ | 17.6 (9.69–38.6) | 17.5 (11.2–23.7) | 12.8 (8.85–15.4) | 22.9 (18.3–30.8) | *** |
D50 disease progression model parameters | |||||
rD50 at MUNIX | 0.30 (0.20–0.41) | 0.26 (0.13–0.39) | 0.16 (0.10–0.26) | 0.39 (0.23–0.51) | *** |
D50 in months | 28.1 (17.3–48.2) | 28.6 (20.3–38.7) | 38.5 (31.0–47.5) | 20.7 (15.6–25.6) | *** |
Demographic and clinical parameters | |||||
Age at MUNIX | 66.3 (58.7–72.4) | 64.1 (57.5–72.4) | 59.3 (54.9–66.4) | 67.1 (58.7–75.4) | ** |
Gender (female/male) | 74/90 | 23/35 | 7/22 | 16/13 | |
Disease duration at MUNIX in months | 15.7 (8.73–30.7) | 13.4 (8.88–19.3) | 13.6 (9.52–16.9) | 13.1 (7.89–23.9) | * |
ALS phenotype | |||||
Classic | 92 | 36 | 23 | 13 | ** |
Bulbar | 57 | 22 | 6 | 16 | ** |
Flail arm | 4 | 0 | 0 | 0 | |
Flail leg | 2 | 0 | 0 | 0 | |
Pyramidal | 4 | 0 | 0 | 0 | |
PLMN | 5 | 0 | 0 | 0 | |
ALSFRS-R Subscores | |||||
Bulbar | 11 (8–12) | 10 (7–12) | 11 (11–12) | 7 (6–10) | *** |
Fine motor | 9 (6–11) | 10 (7–12) | 10 (9–12) | 8 (5–11) | ** |
Gross motor | 9 (5–11) | 9 (6–11) | 9 (7–12) | 8 (5–11) | |
Respiratory | 12 (10–12) | 12 (10–12) | 12 (11–12) | 10 (8–12) | *** |
Values are given as median and interquartile range or numbers.
ALS amyotrophic lateral sclerosis, ALSFRS-R revised amyotrophic lateral sclerosis functional rating scale, CMAP compound muscle action potential, MUNIX motor unit number index, MUSIX motor unit size index, LSPR laboratory-supported probable, PLMN pure lower motor neuron, Sig significant difference between the “differing separation” subgroups (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001) $related to n = 160 at “same separation” and n = 56 at “differing separation”/n = 27 at “high M50 and low D50” because 6 patients had no loss of function in comparison to the mean of CMAP of healthy controls. Phenotype in accordance to Chio et al.25.